Crystal structure of the human RORα ligand binding domain in complex with cholesterol sulfate at 2.2 Å

被引:188
作者
Kallen, J [1 ]
Schlaeppi, JM
Bitsch, F
Delhon, I
Fournier, B
机构
[1] Novartis Pharma AG, Prot Struct Unit, Discovery Technol, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Biomol Prod Unit, Discovery Technol, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Bone Metab Unit, Arthrit & Bone Metab, CH-4002 Basel, Switzerland
关键词
D O I
10.1074/jbc.M400302200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The retinoic acid-related orphan receptor alpha (RORalpha) is an orphan member of the subfamily 1 of nuclear hormone receptors. Our recent structural and functional studies have led to the hypothesis that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. We have now solved the x-ray crystal structure of the ligand binding domain of RORalpha in complex with cholesterol-3-O-sulfate following a ligand exchange experiment. In contrast to the 3-hydroxyl of cholesterol, the 3-O-sulfate group makes additional direct hydrogen bonds with three residues of the RORalpha ligand binding domain, namely NH-Gln(289), NH-Tyr(290), and NH1-Arg(370). When compared with the complex with cholesterol, seven well ordered water molecules have been displaced, and the ligand is slightly shifted toward the hydrophilic part of the ligand binding pocket, which is ideally suited for interactions with a sulfate group. These additional ligand-protein interactions result in an increased affinity of cholesterol sulfate when compared with cholesterol, as shown by mass spectrometry analysis done under native conditions and differential scanning calorimetry. Moreover, mutational studies show that the higher binding affinity of cholesterol sulfate translates into an increased transcriptional activity of RORalpha. Our findings suggest that cholesterol sulfate could play a crucial role in the regulation of RORalpha in vivo.
引用
收藏
页码:14033 / 14038
页数:6
相关论文
共 31 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Identification of natural ligands of retinoic acid receptor-related orphan receptor α ligand-binding domain expressed in Sf9 cells -: a mass spectrometry approach [J].
Bitsch, F ;
Aichholz, R ;
Kallen, J ;
Geisse, S ;
Fournier, B ;
Schlaeppi, JM .
ANALYTICAL BIOCHEMISTRY, 2003, 323 (01) :139-149
[3]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[4]   X-LINKED ICHTHYOSIS - INCREASED BLOOD CHOLESTEROL SULFATE AND ELECTROPHORETIC MOBILITY OF LOW-DENSITY LIPOPROTEIN [J].
EPSTEIN, EH ;
KRAUSS, RM ;
SHACKLETON, CHL .
SCIENCE, 1981, 214 (4521) :659-660
[5]   Regulation of MCF-7 breast cancer cell growth by β-estradiol sulfation [J].
Falany, JL ;
Macrina, N ;
Falany, CN .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 74 (02) :167-176
[6]   ISOFORM-SPECIFIC AMINO-TERMINAL DOMAINS DICTATE DNA-BINDING PROPERTIES OF ROR-ALPHA, A NOVEL FAMILY OF ORPHAN HORMONE NUCLEAR RECEPTORS [J].
GIGUERE, V ;
TINI, M ;
FLOCK, G ;
ONG, E ;
EVANS, RM ;
OTULAKOWSKI, G .
GENES & DEVELOPMENT, 1994, 8 (05) :538-553
[7]   Disruption of the nuclear hormone receptor ROR alpha in staggerer mice [J].
Hamilton, BA ;
Frankel, WN ;
Kerrebrock, AW ;
Hawkins, TL ;
FitzHugh, W ;
Kusumi, K ;
Russell, LB ;
Mueller, KL ;
vanBerkel, V ;
Birren, BW ;
Kruglyak, L ;
Lander, ES .
NATURE, 1996, 379 (6567) :736-739
[8]  
Hanley K, 2001, J LIPID RES, V42, P390
[9]   Age-related phenotypes in the staggerer mouse expand the RORα nuclear receptor's role beyond the cerebellum [J].
Jarvis, CI ;
Staels, B ;
Brugg, B ;
Lemaigre-Dubreuil, Y ;
Tedgui, A ;
Mariani, J .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 186 (01) :1-5
[10]   INCREASED CHOLESTEROL SULFATE AND CHOLESTEROL SULFOTRANSFERASE ACTIVITY IN RELATION TO THE MULTI-STEP PROCESS OF DIFFERENTIATION IN HUMAN EPIDERMAL-KERATINOCYTES [J].
JETTEN, AM ;
GEORGE, MA ;
NERVI, C ;
BOONE, LR ;
REARICK, JI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (02) :203-209